Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis

Published:2020-07-14 Issue:7 Volume:15 Page:e0234818
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Choi Hye Duck^ORCID,Chang Min Jung

Funder

Yeungnam University

Basic Science Research Program through the National Research Foundation of Korea (NRF) founded by the Ministry of Science, ICT and Future Planning

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference87 articles.

1. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers;WJ Gullick;Br Med Bull,1991

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;JG Paez;Science,2004

3. Non-small cell lung cancer. NCCN Clinical practice guidelines in oncology (NCCN guidelines). 2019.

4. Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy;B Coudert;Ann Oncol,2012

5. Erlotinib in previously treated non-small-cell lung cancer;FA Shepherd;N Engl J Med,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral in vivo biodistribution of fluorescent labelled nano lipid carrier system of erlotinib using real time optical imaging technique;International Journal of Pharmaceutics;2024-10

2. New-onset keratitis associated with epidermal growth factor receptor-based targeted therapies in Han Chinese patients with lung cancer: A multi-center cohort study;The Ocular Surface;2024-07

3. Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice;Molecular Pharmaceutics;2023-10-26

4. Development of certain aminoquinazoline scaffolds as potential multitarget anticancer agents with apoptotic and anti-proliferative effects: Design, synthesis and biological evaluation;Bioorganic Chemistry;2023-06

5. Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein–Expressing Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2023-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3